Feb 07, 2017 12:01 pm UTC| Business
DENVER, Feb. 07, 2017 -- Extraction Oil Gas, Inc. (NASDAQ:XOG), (“Extraction,” or the “Company”), an oil and gas exploration and production company with primary assets in the Wattenberg Field in the Denver-Julesburg...
Capnia to Present at the 19th Annual BIO CEO & Investor Conference
Feb 07, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Feb. 07, 2017 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today...
Capnia to Present at the 19th Annual BIO CEO & Investor Conference
Feb 07, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Feb. 07, 2017 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today...
Anavex Reports Fiscal First Quarter 2017 Financial Results
Feb 07, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 07, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Anavex Reports Fiscal First Quarter 2017 Financial Results
Feb 07, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 07, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress
Feb 07, 2017 12:01 pm UTC| Business
- Epidiolex® NDA submission and launch preparation on track -- New Positive Phase 2 glioma data further demonstrates value of cannabinoid pipeline -- Conference call today at 8:30 a.m. EST - LONDON, Feb. 07, 2017 --...
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress
Feb 07, 2017 12:01 pm UTC| Business
- Epidiolex® NDA submission and launch preparation on track -- New Positive Phase 2 glioma data further demonstrates value of cannabinoid pipeline -- Conference call today at 8:30 a.m. EST - LONDON, Feb. 07, 2017 --...